Press Releases

For more information Contact Chris Bogan email:cbogan@bestpracticesllc.com

Search Press Releases By Keyword

Filter By Year Filter By Month

2021

New Report Highlights Expanded Role for Medical Affairs in Product Launch: 60 Medical Leaders

The last decade has seen Medical Affairs move from a support function to a strategic, central function. Change has been constant with Medical becoming the hub for insight and intelligence for the company, taking the lead in shaping the evidence agenda, and establishing excellence in external engagement and value communication.

New Report Tackles How Pharma is Using Social Media for HCP Education

The pandemic had an immediate impact on pharmaceutical medical education programs, with organizations quickly pivoting from live meetings to virtual meetings and other multichannel approaches to delivering medical education.

Tactics to Diffuse Stakeholder Hostility During Product Launch

Launching a new breakthrough medicine is often like a double-edged sword for pharma companies. While some drugs go on to achieve blockbuster status owing to factors such as fulfilling an unmet need or first-mover advantage, other drugs face a hostile response from key stakeholder groups in instances where there is stigma or controversy associated with the condition or its treatment.

Field IIT requests by focusing on your launch and portfolio strategy with data to support your decisions

The careful selection of IITs can be an important link in the chain of new product launch and portfolio management. However, choosing studies which can be properly leveraged to drive the success of launches can be daunting considering shifting launch plans and corporate objectives.

Build a Value Story with a Best-in-class Oncology HEOR Team

Outcomes data, especially in oncology, can be used to gain much-needed advantages at launch, but how do Health Outcomes groups coordinate to make sure each product has enough outcomes data to showcase value? Furthermore, how are these teams being staffed and funded?

Case study on Health Outcomes & Real-World Data driving growth: How "Smart Toothbrushes" have used data analytics and AI in a way biopharma can emulate

In 2018 Colgate partnered with Apple and Kolibree to deliver a smart toothbrush. The "Hum" toothbrush married AI technology, prevention and patient participation to achieve rapid growth in an established market. Pharma leaders can learn many critical lessons from the strategy and success of the "Hum" healthcare product.

Performance benchmarks to best measure the effectiveness of field medical specialists

Medical Affairs leaders must continually refine the structure and activities of their field medical teams to maximize their interactions with thought leaders - and along with this, the performance benchmarks which will best measure the effectiveness of field medical specialists.

Medical Affairs in 2025: A four-year future plan

The last decade has seen Medical Affairs move from a support function to what many view as the third leadership pillar in biopharma. Change has been constant. Moreover, the Covid-19 pandemic has triggered a tsunami of rapid technology and role changes for Medical Affairs.

New Report Presents Strategies and Tactics to Boost Omnichannel Marketing Impact

Maximize your omnichannel marketing strategy using benchmarks from our report around digital marketing service structure, staffing and investment, digital operations, innovative tools, digitizing new product planning and launch, performance measurement, mobile engagement and digital health, and key channels and activities.

New Report Provides Blueprint on Using Disease Awareness to Connect with Patients

Identify most effective disease awareness activities and investment levels for supporting pipeline products during both development and post-marketing periods.

Study: Lock in your launch forecast using insights from successful recent launches

37 launch leaders share how to identify and evaluate launch performance measures in new benchmarking study.

Trends in Digital Biopharma Launches

Over the past year, companies have implemented new initiatives and technologies to further progress their digital launch transformation. Digital approaches can be leveraged to help build effective launch strategies, but how is this shift to digital affecting different parts of the organization?

How to Build Better Bridge and Fast-Start Patient Assistance Programs

Patient assistance programs have become important ways for pharma to help patients navigate expensive therapies or gain access to new products that are pending coverage by payers. Fast start programs are typically patient assistance provided for new drugs with pending coverage approval; bridge programs are patient assistance provided by drug makers to reduce or eliminate costs for eligible individuals.

How to Use a Promotion Review Editor to Streamline the Review Process: 24 Marketing Leaders

The review of advertising and promotional material can be critical and challenging as it involves a deeper knowledge of product and regulations. As more companies create or expand the role of a promotion review editor, Best Practices, LLC conducted a primary research project to probe collaboration approaches, roles and responsibilities, importance and effectiveness of the Promotion Review Editor role within an organization.

Adopting a Fully Digital Launch Model in the Future for Biopharma

Many companies delayed drug launches, paused new clinical trials, and reduced workforces as a result of the global pandemic, making traditional field-based launches impossible. However, after reviewing business, social and market factors, Biohaven pivoted to a full digital launch model and boldly entered the market.

84 Biopharma Leaders Share How Strong Insights Management Can Boost Medical's Impact

Many organizations lack a clear process and strategy for gathering and sharing Medical Insights to inform Medical Affairs strategies and plans; the challenge for Medical Affairs is how to incorporate stronger Insights and Intelligence skills into medical activities and processes.